[1] XU S X,ZHANG W H,WANG Q F,et al.Hepatitis B virus serological screen in a general hospital in Beijing from 2008 to 2018,and challenges to our vaccination policy[J].Vaccine X,2020,4:100057. [2] 唐小敏,令狐艳,张丽,等.2118例住院分娩孕妇乙型肝炎病毒感染血清标志物及病毒载量分析[J].贵州医科大学学报,2019,44(6):716-720. [3] LIU J,LIANG W N,JING W Z,et al.Countdown to 2030:eliminating hepatitis B disease,China[J].Bull World Health Organ,2019,97(3):230-238. [4] 刘达,2022年中国乙肝疫苗行业市场现状与竞争格局分析,疫苗批签发量呈现下降趋势[N],前瞻经济学人,2022-05-27. [5] 戴平. 乙型肝炎病毒PreS1抗原及e抗原表达与血清乙型肝炎病毒DNA表达载量的关系[J].检验医学与临床,2020,17(10):1384-1386. [6] 张庆安. 乙肝患者血清免疫学标志物检测结果与HBV-DNA定性、定量关系的分析[J].山东医药,2012,52(22):74-76. [7] 彭文伟.传染病学[M].第五版,北京:人民出版社,2000,17-20. [8] 熊格,乔斌,李艳.乙型肝炎患者前S1抗原与HBV-DNA和HBeAg的相关性研究[J].海南医学,2016,27(8):1225-1227. [9] YAN Y,SUN H Z,CHANG L,et al.Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection[J].Front Microbiol,2022,13:1063616. [10] 孙珍,赵志军,师志云,等.宁夏地区乙肝病毒感染者HBV基因分型与临床意义[J].宁夏医科大学学报,2014,36(1):34-37. [11] 容莹,郑欣,叶贤林,等.无偿献血者隐匿性乙型肝炎病毒Pre-S/S区变异的研究[J].中国输血杂志,2011,24(7):565-571. [12] MONTALBANO R,HONRATH B,WISSNIOWSKI T T,et al.Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress:involvement of cannabinoid axis in liver cancer cells[J].Oncotarget,2016,7(15):20312-20323. [13] 黄艳萍,祝峰,王新元,等.乙型肝炎前S1、S2抗原与HBV-DNA的相关性分析[J].武警医学,2015,26(6):600-602. [14] 明翠玲,李娅.乙型肝炎PreS1Ag表达与HBV-DNA、HBeAg相关性研究[J].中外医学研究,2016,14(29):56-57. [15] HUANG X Y,QIN Y H,LI W,et al.Molecular analysis of the hepatitis B virus presurface and surface gene in patients from Eastern China with occult hepatitis B[J].J Med Virol,2013,85(6):979-986. [16] 邓燕玲. 乙肝前S1抗原与乙肝五项阳性相关性的研究[J].安徽医药,2013,17(6):1009-1010. [17] SUN H Z,CHANG L,YAN Y,et al.Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2/S promoter activity[J].Antivir Res,2022,208:105448. [18] 宋婷婷,单芙香,程锦泉,等.乙肝疫苗和免疫球蛋白阻断乙肝母婴传播效果研究[J].中华疾病控制杂志,2011,15(6):497-499. |